MEMPHIS, Tenn.--(BUSINESS WIRE)--Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of VERTEX SELECT® CHROMALOY™ Plus Rods. The announcement was made at the 27th annual meeting of the American Association of Neurological Surgeons/ Congress of Neurological Surgeons Section of Disorders of the Spine and Peripheral Nerves in Phoenix.
